In this episode, Kevin Sayer, CEO of Dexcom, discusses the remarkable benefits of a continuous glucose monitor for the diabetes population. Peter shares his own invaluable insights he’s learned from wearing a CGM including the impact of sleep and stress on glucose as well as the unmatched power of a CGM to drive behavioral change. Kevin also reveals some of the exciting partnerships and future advancements of their products benefiting not only those with type 1 and 2 diabetes, but also for the growing community of people interested in optimizing health and wellness. We discuss: • How they met, and Kevin’s path to becoming CEO of Dexcom [7:00]; • How CGM technology works, and what makes Dexcom’s G6 the best model yet [15:15]; • Challenges of working in the US healthcare system and getting CGM insured [21:45]; • Developing an even smaller, more user-friendly, and less costly product while maintaining performance and accuracy [33:15]; • Next thing on the horizon for type 1 diabetes patients [43:30]; • The incredible accuracy of the G6, recommended over-the-counter glucose meters, and the unmatched power of CGM to drive behavioral change [48:15]; • Software improvements for type 2 diabetics, and the remarkable benefits of real-time feedback for driving behavioral change [58:15]; • Dexcom vs. the competitors, the less invasive options, and the fundamental problems needing to be solved with CGM technologies [1:07:00]; • The cost of CGM, why you need a prescription, and when might there be a OTC option? [1:12:00]; • Smartwatch integration, bluetooth technology, and exciting collaborations and partnerships [1:22:00]; • Future places for CGM: Hospitals, nutrition apps, general health and wellness, and more [1:27:15]; • Dexcom’s unique company culture [1:34:15]; • Parenting advice from Kevin [1:37:30]; • Lessons learned through failures and success [1:38:45]; and • More. Learn more at www.PeterAttiaMD.com Connect with Peter on Facebook | Twitter | Instagram.

Release date

Lydbog: 20. maj 2019